Key facts
- It has raised $100K; the latest was Accelerator/Incubator in Jan 2026.
- Notable investors include Mohammed Bin Rashid Innovation Fund, Sanabil Accelerator by Orbit, In5, Orbit Ventures (Venture Capital).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Neulink
- ·The full record, as it builds
Funding rounds
No funding rounds for Neulink are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neulink
Developer of a healthcare platform designed to streamline operations, simplify workflows, and automate essential tasks for pharmacists. The company's platform provides OTC and insurance sales management, detailed reporting and invoicing features, and an inventory management system that are available in one place, and the application updates continuously to enhance features and security, enabling healthcare organizations to manage their workflow and enhance patient care services.
- Sector
- Healthcare
- HQ
- Dubai, United Arab Emirates
- Founded
- 2022
- Employees
- 3
- Website
- neulink.cloud/
- Ownership
- Privately Held (backing)
Neulink doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neulink shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neulink in its N-PORT filings yet. We sweep new filings monthly.